Comparison of sodium-glucose cotransporter-2 (SGLT2) inhibitors to reduce cardiovascular and renal outcomes: a network meta-analysis of randomized controlled trials
Event:
ESC Congress 2023
Topic:
Antidiabetic Pharmacotherapy
Session:
Antidiabetic medications and cardiovascular disease
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
